
Overview
Voxel is a network of diagnostic centers specializing in radiology, nuclear medicine, and advanced technology. The company offers various imaging tests, including CT scans, MRI, PET-CT, SPECT, and fusion biopsy for prostate cancer, as well as treatments like radiosynovectomy and isotope therapy for joint conditions. Voxel has been operating since 2005 and provides online registration for diagnostic examinations.
Financials
The financial statement for 2023 has not yet been filed with the Financial Document Repository (past deadline).
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Stock quotes
- Open
- PLN 141.40
- High
- PLN 142.40
- Low
- PLN 140.00
- Volume
- 9.43K
- Avg. vol.
- 7.89K
- Market cap
- PLN 1.49B
- P/E ratio
- 11.95
- EPS
- PLN 11.85
- Shares outstanding
- 10.5M
- 52-week
- PLN 136.80 – 147.80
- Dividend yield
- 1.77%
- Dividend
- PLN 2.50
- Ex dividend date
- Sep 29, 2026
- ISIN
- PLVOXEL00014
- Exchange
- GPW Main Market
Quarterly results
| Period | Revenue | EBIT | Net profit |
|---|---|---|---|
| Q2 2026 | USD 49.92m | USD 11.66m | USD 8.79m |
| Q1 2026 | USD 42.46m | USD 11.48m | USD 8.62m |
| Q4 2025 | USD 39.08m | USD 8.51m | USD 6.23m |
| Q3 2025 | USD 35.90m | USD 9.21m | USD 6.92m |
Results for Q3 2026:Nov 26, 2026
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2022.
Results vs industry
News
Industry
Bank accounts
Registered as a VAT taxpayer on 2005-07-01. Active
21 2490 0005 0000 4530 2031 1019
63 1600 1462 1087 3147 0000 0023
04 1240 1037 1978 0011 1975 9502
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 22, 2019 | Other notice | |
| Dec 10, 2015 | Other notice | |
| Apr 29, 2013 | Commercial Companies Code notice | |
| Nov 30, 2012 | Other notice |
Public aid
8 public aid cases recorded, with a total value of $2,120,126.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jan 26, 2023 | Aid for research and development projects: industrial research | $914,667 | Prezes Agencji Badań Medycznych | |
| Jan 26, 2023 | Aid for research and development projects: experimental development | $199,189 | Prezes Agencji Badań Medycznych | |
| Feb 10, 2020 | Aid for research and development projects: experimental development | $329,751 | Marszałek Województwa Małopolskiego |
European Funds
4 projects co-financed from European Funds recorded, with total EU co-financing of $1,011,234.
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-03-01 | Przeprowadzenie prac badawczo-rozwojowych mających na celu wdrożenie innowacji procesowej opartej o sztuczną inteligencję w pracowniach diagnostyki obrazowej MRI | $329,925 | Regionalny Program Operacyjny Województwa Małopolskiego na lata 2014-2020 | |
| 2020-01-21 | Rozbudowa działu B+R w celuprowadzenia prac nad nowymi radiofarmaceutykami | $221,612 | Regionalny Program Operacyjny Województwa Małopolskiego na lata 2014-2020 | |
| 2019-03-01 | Przeprowadzenie prac rozwojowych mających na celu wdrożenie innowacyjnej technologii nowej linii radiofarmaceutyków | $403,433 | Regionalny Program Operacyjny Województwa Małopolskiego na lata 2014-2020 |
Tenders
35 tenders recorded as contractor: 7 national ($808,878) and 28 EU ($24,843,251).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Sep 29, 2026 | Dostawa materiałów radioizotopowych | — | Mazowiecki Szpital Wojewódzki Im. Św. Jana Pawła II w Siedlcach sp. z o.o. | |
| Sep 15, 2026 | Udzielanie świadczeń w zakresie badań PET TK oraz PET TK z choliną – w rozpoznaniach onkologicznych z zastosowaniem radiofarmaceutyków z grupy I i II na potrzeby 5 WSZKzP SPZOZ w Krakowie | — | 5 Wojskowy Szpital Kliniczny z Polikliniką Samodzielny Publiczny Zakład Opieki Zdrowotnej | |
| Sep 2, 2026 | Wykonywanie badań obrazowych | — | Górnośląskie Centrum Medyczne Im. Prof. Leszka Gieca Śląskiego Uniwersytetu Medycznego w Katowicach |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Manner of representation
Two members of the management board acting jointly or one member of the management board acting jointly with a commercial proxy are authorized to submit declarations of will and sign documents on behalf of the company.
Supervisory board
Beneficial owners
No beneficial owners recorded for the company Voxel.
Subsidiaries
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| ScanmedS.A. | $266,523,177.15 | scanmed.pl | |
| LUX Med Onkologiasp. z o.o. | $121,974,338.96 | onkologia.luxmed.pl | |
| Mazowiecki Szpital Onkologicznysp. z o.o. | $72,929,509.74 | szpitalonkologiczny.pl | |
| Tomma Diagnostyka ObrazowaS.A. | $41,423,915.29 | tomma.com.pl | |
| ARS Medicalsp. z o.o. | $30,982,068.72 | arsmedical.pila.pl | |
| NU - Med GrupaS.A. | $25,775,184.94 | nu-med.pl | |
| Aldemed Centrum Medycznesp. z o.o. | $17,163,375.93 | aldemed.pl | |
| Prudnickie Centrum MedyczneS.A. | $17,072,715.93 | pcm.prudnik.pl | |
| Centrum Diagnostyki Medycznej Multi-MedS.A. | $14,036,138.38 | multimed.pl | |
| Optima MedycynaS.A. | $13,842,937.36 | optima-medycyna.eu |
Change history
| Date | Event |
|---|---|
| 2025-09-05 | PKD change (Removed: 32.50.Z, 72.19.Z, 85.5, 85.60.Z, 86.90.C, 86.90.E; Added: 26.60.Z, 72.10.Z, 85.59.D, 85.69.Z, 86.91.A, 86.94.Z) |
| 2019-10-03 | PKD change (Removed: 26.60.Z, 32.99.Z, 33.12.Z, 33.13.Z, 33.14.Z, 33.20.Z, 38.12.Z, 38.22.Z, 46.14.Z, 46.46.Z, 50.40.Z, 51.10.Z, 51.21.Z, 52.10.B, 52.21.Z, 52.24.A, 52.24.B, 52.24.C, 52.29.C, 58.11.Z, 58.12.Z, 58.13.Z, 58.14.Z, 58.19.Z, 60.20.Z, 62.01.Z, 62.02.Z, 62.03.Z, 62.09.Z, 63.11.Z, 63.12.Z, 64.92.Z, 64.99.Z, 68.10.Z, 68.20.Z, 70.21.Z, 70.22.Z, 72.11.Z, 74.90.Z, 77.11.Z, 77.12.Z, 77.33.Z, 77.39.Z, 82.11.Z, 82.19.Z, 82.91.Z, 82.99.Z, 86.90.B, 86.90.D, 87.10.Z, 87.20.Z, 87.30.Z, 95.11.Z) |
| 2013-07-31 | Share capital change (10,402,600.00 PLN → 10,502,600.00 PLN) |
| 2013-04-18 | Share capital change (9,732,600.00 PLN → 10,402,600.00 PLN) |
| 2013-03-15 | PKD change (Added: 38.12.Z, 38.22.Z, 50.40.Z, 52.24.A, 52.24.B, 52.24.C, 52.29.C, 77.12.Z) |
FAQ
Last updated: 2026-07-31
